Bristol Myers Squibb Co. (NYSE:BMY) has recently announced suspension of a mid-stage trial of a tentative hepatitis C drug obtained in its $2.5 billion January takeover of Inhibitex Inc. After noticing a heart failure case, the New York-based drugmak statedRead More

Ugandan President Yoweri Museveni has recently advised the public to avoid shaking hands, casual sex and do-it-yourself burials in order to lessen the risk of contracting the deadly Ebola virus after an epidemic killed 14 people and put many moreRead More

U.S. stocks are mixed today as investors have adopted cautious approach in placing big bets before two big meetings by U.S. and European central bankers. The Dow Jones Industrial Average (INDEXDJX:.DJI) is struggling to stay in positive territory and atRead More

After the National Pharmaceutical Pricing Authority in India has discarded the requests of Eli Lilly & Co. (NYSE:LLY) and two others to raise prices of their insulin brands, they are ready to appeal against the drug price regulator’s decision toRead More

The request from key pharma companies such as Eli Lilly & Co. (NYSE:LLY) and Biocon to raise the price of insulin used for diabetes treatment has been turned down by National Pharmaceutical Pricing Authority (NPPA), the national body set upRead More

The U.S. Food and Drug Administration, after a 13-year dry spell, recently provided an approval for two new drugs including Belviq and Qsymia. The question will be about how to get a prescription for them. The answer may perhaps dependRead More